4-(3-METHOXYPHENYL)PICOLINIC ACID
|
- $434 - $885
- Product name: 4-(3-METHOXYPHENYL)PICOLINIC ACID
- CAS: 1255637-89-8
- MF: C13H11NO3
- MW: 229.23
- EINECS:
- MDL Number:MFCD09027592
- Synonyms:4-(3-Methoxyphenyl)pyridine-2-carboxylic acid;4-(3-METHOXYPHENYL)PICOLINIC ACID;2-Pyridinecarboxylic acid, 4-(3-methoxyphenyl)-;4-(3-Methoxyphenyl)-2-pyridinecarboxylic acid
4 prices
Selected condition：
Brand
- American Custom Chemicals Corporation
- Chemenu
- Crysdot
- Matrix Scientific
Package
- 5MG
- 1g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0372639
- Product description4-(3-METHOXYPHENYL)PICOLINIC ACID 95.00%
- Packaging5MG
- Price$501.72
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM324896
- Product description4-(3-Methoxyphenyl)picolinicacid 95%
- Packaging1g
- Price$434
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11314756
- Product description4-(3-Methoxyphenyl)picolinicacid 95+%
- Packaging1g
- Price$459
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number082432
- Product description4-(3-Methoxyphenyl)pyridine-2-carboxylic acid 97%
- Packaging1g
- Price$885
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | CHM0372639 | 4-(3-METHOXYPHENYL)PICOLINIC ACID 95.00% | 5MG | $501.72 | 2021-12-16 | Buy |
| Chemenu | CM324896 | 4-(3-Methoxyphenyl)picolinicacid 95% | 1g | $434 | 2021-12-16 | Buy |
| Crysdot | CD11314756 | 4-(3-Methoxyphenyl)picolinicacid 95+% | 1g | $459 | 2021-12-16 | Buy |
| Matrix Scientific | 082432 | 4-(3-Methoxyphenyl)pyridine-2-carboxylic acid 97% | 1g | $885 | 2021-12-16 | Buy |
Properties
Boiling point :428.5±35.0 °C(Predicted)
Density :1.242±0.06 g/cm3(Predicted)
pka :0.98±0.50(Predicted)
Density :1.242±0.06 g/cm3(Predicted)
pka :0.98±0.50(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|